Rabbit Anti-KLF13 Polyclonal Antibody – Cat# MBS620076

KLF13 Antibody – Rabbit Polyclonal

Name: KLF13 Antibody; Polyclonal; Rabbit; Human-Reactive; MyBioSource
Brand: MyBioSource
SKU: MBS620076
Price: 660 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS620076

RANTES factor of Late Activated T Lymphocytes-1 (RFLAT-1) is a novel protein belonging to the TFIIIA-like zinc finger protein superfamily and binds to the A site of RANTES (Regulated upon Activation, Normal T cell Expressed and Secreted) chemokine. RANTES is… More details

$660 / 0.1 mL +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

KLF13, Polyclonal Antibody

Full Product Name

KLF13 (Kruppel-like Factor 13, Basic Transcription Element Binding Protein 3, BTE Binding Protein 3, BTEB3, FKLF2, Novel Sp1-like Zinc Finger Transcription Factor, NSLP1, RANTES Factor of Late Activated T Lymphocytes 1, RFLAT1, Transcription Factor NSLP1)

Product Gene Name

anti-KLF13 antibody

Product Synonym Names

Anti -KLF13 (Kruppel-like Factor 13, Basic Transcription Element Binding Protein 3, BTE Binding Protein 3, BTEB3, FKLF2, Novel Sp1-like Zinc Finger Transcription Factor, NSLP1, RANTES Factor of Late Activated T Lymphocytes 1, RFLAT1, Transcription Factor NSLP1)

Clonality

Polyclonal

Isotype

IgG

Host

Rabbit

Species Reactivity

Human

Form/Format

PBS with 0.02% sodium azide

Purity/Purification

Purified
Purified

Specificity

Reacts with human RFLAT-1.

Preparation and Storage

May be stored at 4 degree C for short-term only. For long-term storage and to avoid repeated freezing and thawing, add sterile glycerol (40-50%), aliquot and store at -20 degree C. Aliquots are stable for at least 3 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Molecular Weight

31,180 Da

Chromosome Location

Chromosome: 15; NC_000015.9 (31619083..31670102). Location: 15q12

OMIM

605328

3D Structure

ModBase 3D Structure for Q9Y2Y9

Product Categories/Family for anti-KLF13 antibody

Antibodies; Abs to Transcription Factors; Zinc (Ring) Finger

Applications Tested/Suitable for anti-KLF13 antibody

Western Blot (WB)

Application Notes for anti-KLF13 antibody

Suitable for use in Western Blot.

Other Notes

Small volumes of anti-KLF13 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for KLF13 purchase

MBS620076 is an antibody targeting KLF13. Also known as KLF13 (Kruppel-like Factor 13, Basic Transcription Element Binding Protein 3, BTE Binding Protein 3, BTEB3, FKLF2, Novel Sp1-like Zinc Finger Transcription Factor, NSLP1, RANTES Factor of Late Activated T Lymphocytes 1, RFLAT1, Transcription Factor NSLP1). Reactive in Human. Host: Rabbit.

Additional Details

NCBI/Uniprot data below describe general gene information for KLF13. It may not necessarily be applicable to this product.

NCBI GI #

37693995

NCBI GeneID

51621

NCBI Accession #

NP_057079.2

UniProt Primary Accession #

Q9Y2Y9

UniProt Secondary Accession #

Q9Y356

UniProt Related Accession #

Q9Y2Y9

GenBank Nucleotide #

NM_015995.2

NCBI Official Full Name

Krueppel-like factor 13

NCBI Official Synonym Full Names

Kruppel-like factor 13

NCBI Official Symbol

KLF13

NCBI Official Synonym Symbols

BTEB3; FKLF2; NSLP1; RFLAT1; RFLAT-1

UniProt Protein Name

Krueppel-like factor 13

UniProt Synonym Protein Names

Basic transcription element-binding protein 3; BTE-binding protein 3; Novel Sp1-like zinc finger transcription factor 1; RANTES factor of late activated T-lymphocytes 1; RFLAT-1; Transcription factor BTEB3; Transcription factor NSLP1

Protein Family

Krueppel-like factor

UniProt Gene Name

KLF13

UniProt Synonym Gene Names

BTEB3; NSLP1

UniProt Entry Name

KLF13_HUMAN

NCBI Protein Information

Krueppel-like factor 13; OTTHUMP00000159587; BTE-binding protein 3; transcription factor BTEB3; transcription factor NSLP1; Sp1 like zinc finger transcription factor; basic transcription element binding protein 3; basic transcription element-binding protein 3; RANTES factor of late activated T lymphocytes-1; RANTES factor of late activated T-lymphocytes 1; novel Sp1-like zinc finger transcription factor 1

NCBI Summary for KLF13

KLF13 belongs to a family of transcription factors that contain 3 classical zinc finger DNA-binding domains consisting of a zinc atom tetrahedrally coordinated by 2 cysteines and 2 histidines (C2H2 motif). These transcription factors bind to GC-rich sequences and related GT and CACCC boxes (Scohy et al., 2000 [PubMed 11087666]).[supplied by OMIM]

UniProt Comments for KLF13

KLF13: Represses transcription by binding to the BTE site, a GC-rich DNA element, in competition with the activator SP1. It also represses transcription by interacting with the corepressor Sin3A and HDAC1. Activates RANTES expression in T-cells. Belongs to the Sp1 C2H2-type zinc-finger protein family.

Protein type: C2H2-type zinc finger protein; DNA-binding

Chromosomal Location of Human Ortholog: 15q12

Cellular Component: nucleus

Molecular Function: protein binding; DNA binding; metal ion binding

Biological Process: transcription from RNA polymerase II promoter; negative regulation of cell proliferation; negative regulation of erythrocyte differentiation; positive regulation of transcription from RNA polymerase II promoter

Disease: Chromosome 15q13.3 Deletion Syndrome

Research Articles on KLF13

1. No associations were found between maternal genetic polymorphisms in RANTES (-403G/A) and mother-to-child HIV-1 transmission; plasma, cervical and breastmilk viral loads; or breastmilk chemokine concentrations.

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with anti-KLF13 antibody

Reference Product	PubMed Publications
PRPF4B antibody	>1 publications with KLF13 and PRPF4B

Diseases associated with anti-KLF13 antibody

Disease Name	Pubmed Publications
Congenital Abnormalities Antibodies	>4 publications with KLF13 and Congenital Abnormalities
Epilepsy Antibodies	>2 publications with KLF13 and Epilepsy
Nervous System Diseases Antibodies	>2 publications with KLF13 and Nervous System Diseases
Inflammation Antibodies	>2 publications with KLF13 and Inflammation
Heart Defects, Congenital Antibodies	>2 publications with KLF13 and Heart Defects, Congenital
Seizures Antibodies	>2 publications with KLF13 and Seizures
Carcinoma Antibodies	>1 publications with KLF13 and Carcinoma
Head and Neck Neoplasms Antibodies	>1 publications with KLF13 and Head and Neck Neoplasms
Epilepsy, Absence Antibodies	>1 publications with KLF13 and Epilepsy, Absence
Central Nervous System Diseases Antibodies	>1 publications with KLF13 and Central Nervous System Diseases

Organs/Tissues associated with anti-KLF13 antibody

Organ/Tissue Name	Pubmed Publications
Blood Antibodies	>12 publications with KLF13 and Blood
Muscle Antibodies	>5 publications with KLF13 and Muscle
Heart Antibodies	>5 publications with KLF13 and Heart
Bone Antibodies	>3 publications with KLF13 and Bone
Eye Antibodies	>2 publications with KLF13 and Eye
Thymus Antibodies	>2 publications with KLF13 and Thymus
Vascular Antibodies	>2 publications with KLF13 and Vascular
Spleen Antibodies	>2 publications with KLF13 and Spleen
Bone Marrow Antibodies	>2 publications with KLF13 and Bone Marrow
Kidney Antibodies	>1 publications with KLF13 and Kidney